Polomar Health Services, Inc.
Polomar Health Services, Inc.
Your view on PMHS
Overview
What the company does, where it operates, and who runs it.
About Polomar Health Services, Inc.
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Terrence Tierney
- Headquarters
- 10940 Wilshire Boulevard, Los Angeles, CA, US
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Terrence Tierney
- Headquarters
- 10940 Wilshire Boulevard, Los Angeles, CA, US
Polomar Health Services, Inc. operates as a retail compounding pharmacy.
The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin, as well as compounded erectile dysfunction medications inhalable sildenafil.
It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker's nevus, vitiligo, and other common skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Polomar Health Services, Inc., and the rating behind it. PMHS last traded at $0.16; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Polomar Health Services, Inc.. Starting points for Polomar Health Services, Inc.: EPS -$0.34, beta -0.98 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Polomar Health Services, Inc.. Polomar Health Services, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Polomar Health Services, Inc.. Trailing twelve-month EPS for Polomar Health Services, Inc. stands at -$0.34. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Polomar Health Services, Inc.. Polomar Health Services, Inc. has reported as a listed company since 2009. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Polomar Health Services, Inc. valued side by side against its closest peers. Polomar Health Services, Inc. is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Polomar Health Services, Inc., and how their positions are changing. At a $4.5M market value, institutional positions materially move Polomar Health Services, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Polomar Health Services, Inc. executives and directors. Shares of Polomar Health Services, Inc. have traded between $0.06 and $0.80 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Polomar Health Services, Inc.. Polomar Health Services, Inc. is a $4.5M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Polomar Health Services, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Polomar Health Services, Inc.. Coverage tracks Polomar Health Services, Inc. within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.